You are here

  • Home
  • Archive
  • Volume 76, Issue 9
  • A randomised, double-blind trial to demonstrate bioequivalence of GP2013 and reference rituximab combined with methotrexate in patients with active rheumatoid arthritis

Article metrics

Article menu

Download PDFPDF

Clinical and epidemiological research
Concise report
A randomised, double-blind trial to demonstrate bioequivalence of GP2013 and reference rituximab combined with methotrexate in patients with active rheumatoid arthritis

 

Online download statistics by month:

Online download statistics by month: June 2017 to March 2024

AbstractFullPdf
Jun 2017549701341
Jul 2017455510252
Aug 2017603607226
Sep 2017352356169
Oct 2017219218113
Nov 201734032976
Dec 201713413448
Jan 201810610649
Feb 201813612365
Mar 201811912056
Apr 201815115163
May 201811711854
Jun 201811511556
Jul 201810610646
Aug 201815115174
Sep 201811511551
Oct 201818318374
Nov 201812612671
Dec 201811511539
Jan 201914114146
Feb 201911011236
Mar 201910210253
Apr 2019857864
May 2019595735
Jun 2019897955
Jul 201910510442
Aug 2019565637
Sep 2019747531
Oct 2019777732
Nov 2019606024
Dec 2019444424
Jan 2020535330
Feb 2020767630
Mar 2020474730
Apr 2020444425
May 2020838223
Jun 2020585740
Jul 2020686852
Aug 2020555530
Sep 2020777730
Oct 2020686841
Nov 2020606035
Dec 2020858446
Jan 2021383832
Feb 2021363630
Mar 2021555532
Apr 2021464525
May 2021575725
Jun 2021393821
Jul 2021393924
Aug 2021373624
Sep 2021434321
Oct 2021343426
Nov 2021393928
Dec 2021626114
Jan 2022646615
Feb 2022343417
Mar 2022535323
Apr 2022667434
May 2022616128
Jun 2022676721
Jul 2022293111
Aug 2022646516
Sep 2022575526
Oct 2022636015
Nov 2022505022
Dec 202227277
Jan 2023414214
Feb 2023525211
Mar 2023353517
Apr 2023242519
May 2023353523
Jun 2023474720
Jul 2023545422
Aug 2023333315
Sep 2023434319
Oct 2023919110
Nov 202319219216
Dec 2023505012
Jan 202455559
Feb 2024373715
Mar 2024444748
Total796181423621